• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全外显子组测序揭示肥厚型心肌病的突变特征。

Whole-Exome Sequencing Reveals Mutational Signature of Hypertrophic Cardiomyopathy.

作者信息

Wang Xi-Qin, Yuan Fang, Yu Bao-Rui

机构信息

Department of Internal Medicine, Yuhua Yunfang Integrated Traditional Chinese and Western Medicine Clinic, Shijiazhuang, Hebei, 050023, People's Republic of China.

Department of Cardiovascular Medicine, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, 450000, People's Republic of China.

出版信息

Int J Gen Med. 2023 Oct 11;16:4617-4628. doi: 10.2147/IJGM.S422598. eCollection 2023.

DOI:10.2147/IJGM.S422598
PMID:37850193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577257/
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM) is an extremely insidious and lethal disease caused by genetic variation. It has been studied for nearly 70 years since its discovery, but its cause of the disease remains a mystery. This study is aimed to explore the genetic pathogenesis of HCM in order to provide new insight for the diagnosis and treatment of HCM.

METHODS

Patients with HCM at 4 hospitals from January 1, 2020, to December 31, 2021, were collected. Peripheral blood of these patients was collected for whole exome sequencing. Moreover, data on the HCM transcriptome were analyzed in the GEO database.

RESULTS

Totally, 14 patients were enrolled, and 6 single-nucleotide variation (SNV) mutant genes represented by MUC12 were observed. Most of the gene mutations in HCM patients were synonymous and non-synonymous, and the types of base mutations were mainly C > T and G > A. Copy number variants (CNVs) predominantly occurred on chromosome 1 in HCM patients. Furthermore, we found that the only ATP2A2 gene was differentially expressed in 3 groups of transcriptome data in GEO database, and the presence of ATP2A2 mutation in 10 samples was observed in this study.

CONCLUSION

In summary, 7 mutated genes represented by MUC12 and ATP2A2 were found in this study, which may provide novel insights into the pathogenic mechanism of HCM.

摘要

背景

肥厚型心肌病(HCM)是一种由基因变异引起的极其隐匿且致命的疾病。自发现以来,对其研究已近70年,但病因仍不明。本研究旨在探索HCM的遗传发病机制,为HCM的诊断和治疗提供新见解。

方法

收集2020年1月1日至2021年12月31日期间4家医院的HCM患者。采集这些患者的外周血进行全外显子组测序。此外,在GEO数据库中分析HCM转录组数据。

结果

共纳入14例患者,观察到以MUC12为代表的6个单核苷酸变异(SNV)突变基因。HCM患者的基因突变大多为同义突变和非同义突变,碱基突变类型主要为C>T和G>A。HCM患者的拷贝数变异(CNV)主要发生在1号染色体上。此外,我们发现GEO数据库中3组转录组数据中仅ATP2A2基因存在差异表达,本研究在10个样本中观察到ATP2A2突变的存在。

结论

综上所述,本研究发现了以MUC12和ATP2A2为代表的7个突变基因,这可能为HCM的致病机制提供新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/5fba4aec0b6c/IJGM-16-4617-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/9e160dbfa64a/IJGM-16-4617-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/5dde4d92b224/IJGM-16-4617-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/0531750ed670/IJGM-16-4617-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/2b5a4db27979/IJGM-16-4617-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/5fba4aec0b6c/IJGM-16-4617-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/9e160dbfa64a/IJGM-16-4617-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/5dde4d92b224/IJGM-16-4617-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/0531750ed670/IJGM-16-4617-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/2b5a4db27979/IJGM-16-4617-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d12/10577257/5fba4aec0b6c/IJGM-16-4617-g0005.jpg

相似文献

1
Whole-Exome Sequencing Reveals Mutational Signature of Hypertrophic Cardiomyopathy.全外显子组测序揭示肥厚型心肌病的突变特征。
Int J Gen Med. 2023 Oct 11;16:4617-4628. doi: 10.2147/IJGM.S422598. eCollection 2023.
2
Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.使用高通量靶向外显子组测序技术筛查肥厚型心肌病中的拷贝数变异。
Eur J Med Genet. 2015 Nov;58(11):611-6. doi: 10.1016/j.ejmg.2015.10.001. Epub 2015 Oct 9.
3
MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.MYH7B 变异通过激活 CaMK 信号通路引起肥厚型心肌病。
Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.
4
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy.俄罗斯肥厚型心肌病患者的靶向外显子组分析。
Mol Genet Genomic Med. 2021 Nov;9(11):e1808. doi: 10.1002/mgg3.1808. Epub 2021 Oct 1.
5
Whole-exome sequencing reveals MYH7 p.R671C mutation in three different phenotypes of familial hypertrophic cardiomyopathy.全外显子组测序揭示了家族性肥厚型心肌病三种不同表型中的MYH7基因p.R671C突变。
Exp Ther Med. 2021 Sep;22(3):1002. doi: 10.3892/etm.2021.10434. Epub 2021 Jul 15.
6
Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family with hypertrophic cardiomyopathy.外显子组测序在中国肥厚型心肌病家系中鉴定出 FHOD3 p.S527del 突变。
J Gene Med. 2020 Mar;22(3):e3146. doi: 10.1002/jgm.3146. Epub 2020 Jan 14.
7
Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.全外显子组测序结合综合变异注释预测可鉴定肥厚型心肌病中一种致病性肌球蛋白必需轻链变异体。
J Cardiol. 2016 Feb;67(2):133-9. doi: 10.1016/j.jjcc.2015.09.003. Epub 2015 Oct 9.
8
[Gene Analysis for the Sudden Death of Hypertrophic Cardiomyopathy by Whole Exome Sequencing.].[肥厚型心肌病猝死的全外显子组测序基因分析。]
Fa Yi Xue Za Zhi. 2017 Aug;33(4):339-343. doi: 10.3969/j.issn.1004-5619.2017.04.001. Epub 2017 Aug 25.
9
A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.肥厚型心肌病潜在的寡基因病因:一种典型的单基因疾病。
Circ Res. 2017 Mar 31;120(7):1084-1090. doi: 10.1161/CIRCRESAHA.116.310559. Epub 2017 Feb 21.
10
Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.全外显子组测序鉴定出与严重家族性肥厚型心肌病相关的MYBPC3基因罕见复合杂合突变。
Eur J Med Genet. 2018 Aug;61(8):434-441. doi: 10.1016/j.ejmg.2018.03.001. Epub 2018 Mar 8.

引用本文的文献

1
The Diagnostic Value of Copy Number Variants in Genetic Cardiomyopathies and Channelopathies.拷贝数变异在遗传性心肌病和离子通道病中的诊断价值
J Cardiovasc Dev Dis. 2025 Jul 4;12(7):258. doi: 10.3390/jcdd12070258.
2
Transcriptomic analysis and machine learning modeling identifies novel biomarkers and genetic characteristics of hypertrophic cardiomyopathy.转录组分析和机器学习建模确定了肥厚型心肌病的新型生物标志物和遗传特征。
Front Genet. 2025 Jun 17;16:1596049. doi: 10.3389/fgene.2025.1596049. eCollection 2025.

本文引用的文献

1
Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy.对肥厚型心肌病发病机制的当前假说的批判性评价。
Int J Mol Sci. 2022 Feb 16;23(4):2195. doi: 10.3390/ijms23042195.
2
Whole-exome sequencing reveals MYH7 p.R671C mutation in three different phenotypes of familial hypertrophic cardiomyopathy.全外显子组测序揭示了家族性肥厚型心肌病三种不同表型中的MYH7基因p.R671C突变。
Exp Ther Med. 2021 Sep;22(3):1002. doi: 10.3892/etm.2021.10434. Epub 2021 Jul 15.
3
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy.
蛋白质组学和功能研究揭示去酪氨酸化微管蛋白作为致肌节突变性肥厚型心肌病的治疗靶点。
Circ Heart Fail. 2021 Jan;14(1):e007022. doi: 10.1161/CIRCHEARTFAILURE.120.007022. Epub 2021 Jan 12.
4
Genetics of hypertrophic cardiomyopathy: what is the next step?肥厚型心肌病的遗传学:下一步是什么?
Heart. 2020 Sep;106(17):1291-1292. doi: 10.1136/heartjnl-2020-317043. Epub 2020 Jun 16.
5
Mitochondrial Energetics and Ca2-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy.梗阻性肥厚型心肌病中的线粒体能量代谢与钙激活ATP酶
J Clin Med. 2020 Jun 9;9(6):1799. doi: 10.3390/jcm9061799.
6
A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.MYBPC3 中的提前终止密码子突变通过非编码介导的衰变的慢性激活导致肥厚型心肌病。
Circulation. 2019 Feb 5;139(6):799-811. doi: 10.1161/CIRCULATIONAHA.118.034624.
7
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition.肥厚型心肌病是由心肌球蛋白功能和自身抑制的不同程度损伤引起的。
Nat Commun. 2018 Oct 1;9(1):4019. doi: 10.1038/s41467-018-06191-4.
8
Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy.扩张型和肥厚型心肌病病例评估中全外显子组测序的覆盖度和诊断收益。
Sci Rep. 2018 Jul 18;8(1):10846. doi: 10.1038/s41598-018-29263-3.
9
Global Burden of Hypertrophic Cardiomyopathy.肥厚型心肌病的全球负担
JACC Heart Fail. 2018 May;6(5):376-378. doi: 10.1016/j.jchf.2018.03.004.
10
Whole exome sequencing identifies novel candidate mutations in a Chinese family with left ventricular noncompaction.全外显子组测序在一个中国左心室致密化不全家系中发现新的候选突变。
Mol Med Rep. 2018 May;17(5):7325-7330. doi: 10.3892/mmr.2018.8777. Epub 2018 Mar 19.